Analyst
Managing Partner
Head of Investor Relations
InfuSystem Holdings, Inc (INFU)Analyst
Lytham Partners
Analyst
Managing Partner at Lytham Partners
Head of Investor Relations
Azz Inc (AZZ)Head of Investor Relations
Immucell Corp (ICCC)Equibles does not estimate personal net worth.
Joe Dorame is recorded as Analyst at Managing Partner, Head of Investor Relations at InfuSystem Holdings, Inc (INFU), Analyst at Lytham Partners, Analyst at Managing Partner at Lytham Partners, Head of Investor Relations at Azz Inc (AZZ) and Head of Investor Relations at Immucell Corp (ICCC). Joe Dorame has spoken on 22 earnings calls across 2 companies, most recently for InfuSystem Holdings, Inc on November 4, 2025. Those appearances were for InfuSystem Holdings, Inc (INFU) and Azz Inc (AZZ). InfuSystem Holdings, Inc is classified in the Medical Devices industry within the Healthcare sector. Azz Inc is classified in the Specialty Business Services industry within the Industrials sector. Other leadership on record at InfuSystem Holdings, Inc includes Carrie Lachance (CEO, COO and Board Member), Richard DiIorio (CEO), Beverly Huss (Chairman and Board Member) and 7 others.
“Good morning, and thank you for joining us today to review InfuSystem's Third Quarter 2025 Financial Results ended September 30, 2025. With us today on the call are Carrie Lachance, Chief Executive Officer; and Barry Steele, Chief Financial Officer.”
“Good morning, and thank you for joining us today to review InfuSystem's first quarter 2025 financial results ended March 31, 2025. With us today on the call are Rich DiIorio, outgoing Chief Executive Officer, Carrie Lachance, Chief Operating Officer and incoming CEO, and Barry Steele, Chief Financial Officer.”
“Good morning, and thank you for joining us today to review InfuSystem's third quarter 2024 financial results ended September 30, 2024. With us today on the call are Rich Dilorio, Chief Executive Officer; Barry Steele, Chief Financial Officer; and Carrie Lachance, President and Chief Operating Officer.”
“Good morning, and thank you for joining us today to review InfuSystem's second quarter 2024 financial results ended June 30, 2024. With us today on the call are Rich Dilorio, Chief Executive Officer; Barry Steele, Chief Financial Officer; and Carrie Lachance, President and Chief Operating Officer.”
“Good morning, and thank you for joining us today to review InfuSystem's First Quarter 2024 financial results ended March 31, 2024. With us today on the call are Rich Dilorio, Chief Executive Officer; Barry Steele, Chief Financial Officer; and Carrie Lachance, President and Chief Operating Officer.”
Managing Partner
Analyst
Source not stated
Lytham Partners
Analyst
Source not stated
Managing Partner at Lytham Partners
Analyst
Source not stated
Medical Devices · Healthcare
Head of Investor Relations
AZZ
Specialty Business Services · Industrials
Head of Investor Relations
